Related Experiment Videos
Hematogenous infection of total joint implants: a report of multiple joint infections in three patients
Abstract:
Three patients had hematogenous infections caused by the same organism (as determined by identical antibiotic sensitivity profiles) in more than one joint. In each of the patients, the same infecting organism had also been recovered from a previous distant infection. Evidence that sepsis resulted from late hematogenous contamination is overwhelming. All three cases clearly had at least some late total joint infection which was not from organisms introduced at the time of total hip arthroplasty but from hematogenous contamination from a distant site occurring at a late date unknown to the surgeon. Patients with a total joint arthroplasty should probably have systemic antibiotic coverage to protect the prosthetic joint against hematogenous contamination from distant sites of infection and from potential bacteremia induced during medical or dental procedures.
Insights
Hematogenous infections can affect multiple joints in patients with total joint arthroplasty. Distant infections may cause late prosthetic joint contamination, necessitating antibiotic prophylaxis.
Area of Science:
- Orthopedics
- Infectious Diseases
- Microbiology
Background:
- Total joint arthroplasty (TJA) is a common procedure to restore joint function.
- Prosthetic joint infections (PJIs) are a serious complication, often requiring revision surgery.
- Hematogenous seeding is a known, albeit less common, cause of PJI.
Observation:
- Three patients with TJA developed infections in multiple joints caused by the same organism.
- Identical antibiotic sensitivity profiles confirmed the same organism in different joints.
- The infecting organism was previously isolated from a distant infection site in each patient.
Findings:
- Evidence strongly suggests late hematogenous contamination from a distant infection site as the cause of PJI.
- Infections were not introduced during the initial arthroplasty surgery.
- The timing of hematogenous seeding was unknown to the surgical team.
Implications:
- Patients with TJA may benefit from systemic antibiotic coverage to prevent hematogenous seeding.
- Prophylactic antibiotics could mitigate the risk of PJI from distant infections and bacteremia.
- Further research is needed to establish optimal antibiotic prophylaxis protocols for TJA patients.